| |
Culture positive (%)
|
Gram-positive bacteria (%)
|
S. aureus (%)
|
MRSA (%)
|
|---|
|
Clinical specimen
|
|
Urine (n = 859)
|
225 (26.0%)
|
22 (9.8%)
|
8 (3.5%)
|
3 (37.5)
|
|
Pus (n = 52)
|
41 (78.8%)
|
32 (78.5%)
|
16 (39.2%)
|
8 (50%)
|
|
Blood (n = 50)
|
21 (42%)
|
9 (42.9%)
|
4 (19.1%)
|
1 (25%)
|
|
Sputum (n = 41)
|
23 (56.1%)
|
14 (60.9%)
|
6 (26.1%)
|
2 (33.3%)
|
|
*Body fluids (n = 25)
|
17 (68.0%)
|
5 (29.41%)
|
4 (23.5%)
|
1 (25%)
|
|
Hospital care for patients
|
|
Outpatient care (n = 752)
|
215 (28.5%)
|
49 (22.8%)
|
21 (9.8%)
|
8(38.0%)
|
|
Inpatient care (n = 275)
|
107 (38.9%)
|
33 (12%)
|
17 (15.8%)
|
7 (41.1%)
|
|
Sex of patients
|
|
Male (n = 400)
|
109 (27.3%)
|
36 (33.0%)
|
18 (16.5%)
|
9 (50%)
|
|
Female (n = 627)
|
212 (33.81%)
|
46 (21.7%)
|
20 (9.4%)
|
6 (30%)
|
|
Total (n = 1027)
|
321 (31.3%)
|
82 (25.5%)
|
38 (11.8%)
|
15 (39.4%)
|
- S. aureus; *body fluids = CSF, synovial fluid, pleural fluid, throat swabs, vaginal swabs; percentage calculated on respective row total of preceding columnsIn susceptibility testing, all isolates of S. aureus were susceptible to vancomycin and 33 (86.8%) were susceptible to amikacin. All isolates were resistant to penicillin-G and ampicillin (Table 2). Also, 25 (67.5%) of S. aureus were MDR. Of 38 S. aureus, 19 (50%) were screened as MRSA, of which, 15 (39.4%) were confirmed MRSA phenotypically
- MRSA methicillin-resistant
